Mar 18, 2025 4:05 PM EDT Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results
Feb 25, 2025 6:00 AM EST Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
Feb 3, 2025 6:00 AM EST TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
Jan 28, 2025 4:01 PM EST Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
Dec 5, 2024 4:05 PM EST Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Nov 7, 2024 4:01 PM EST Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
Oct 15, 2024 4:05 PM EDT Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024